海尔生物股价微跌0.26% 与泰国医疗集团达成战略合作

Core Viewpoint - Haier Biomedical is a service provider for life sciences and medical innovation digital solutions, focusing on low-temperature storage, laboratory solutions, smart medication, and blood technology, with products covering over 150 countries and regions [1] Group 1: Stock Performance - As of August 20, 2025, Haier Biomedical's stock price closed at 34.91 yuan, down 0.09 yuan, a decrease of 0.26% from the previous trading day [1] - The trading volume on that day was 41,111 hands, with a transaction amount of 1.42 billion yuan [1] Group 2: Strategic Partnerships - On August 19, 2025, Haier Biomedical signed a strategic cooperation agreement with Thailand's RAM Medical Group, focusing on pharmacy automation and smart healthcare solutions [1] - RAM Medical Group is the second-largest private hospital group in Thailand, operating 50 hospitals [1] - The agreement includes a pilot project for pharmacy automation solutions, covering outpatient pharmacy automation systems and intelligent inventory management modules [1] Group 3: Financial Updates - Haier Biomedical announced it will hold a semi-annual performance briefing on August 28, 2025 [1] - On August 20, 2025, the net inflow of main funds into Haier Biomedical was 389,900 yuan, with a cumulative net inflow of 1.65 million yuan over the past five days [1]